Fubao Wang

Health Technology

Consumer Services

Profile

Fubao Wang is a Senior VP & Head-Regulatory Affairs at Prime Medicine, Inc. He previously worked as a Director-Regulatory Affairs at Merck & Co., Inc., Vice President & Head-Regulatory at Sarepta Therapeutics, Inc., Associate Vice President at Sanofi, and Senior Vice President & Head-Regulatory Affairs at Asklepios BioPharmaceutical,.
Inc. Wang holds a doctorate from Ruprecht-Karls-Universität Heidelberg and undergraduate and graduate degrees from Nankai University.

Fubao Wang active positions

Companies	Position	Start
PRIME MEDICINE, INC.	General Counsel	-

All active positions of Fubao Wang

Former positions of Fubao Wang

Companies	Position	End
SANOFI	Corporate Officer/Principal	-
SAREPTA THERAPEUTICS, INC.	General Counsel	-
MERCK & CO., INC.	General Counsel	-
Asklepios BioPharmaceutical, Inc. Asklepios BioPharmaceutical, Inc. BiotechnologyHealth Technology Asklepios BioPharmaceutical, Inc. operates as a gene therapy-based company. It engages in capsid development, scaled manufacturing, and a portfolio of therapeutic programs. The company was founded by Richard Jude Samulski, Xiao Xiao, and Sheila A. Mikhail in 2001 and is headquartered in Durham, NC.	General Counsel	-

See the detail of Fubao Wang's experience

Training of Fubao Wang

Ruprecht-Karls-Universität Heidelberg	Doctorate Degree
Nankai University	Graduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Fubao Wang's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	4
PRIME MEDICINE, INC.	Health Technology
SAREPTA THERAPEUTICS, INC.	Health Technology
MERCK & CO., INC.	Health Technology
SANOFI	Health Technology

Private companies	1
Asklepios BioPharmaceutical, Inc. Asklepios BioPharmaceutical, Inc. BiotechnologyHealth Technology Asklepios BioPharmaceutical, Inc. operates as a gene therapy-based company. It engages in capsid development, scaled manufacturing, and a portfolio of therapeutic programs. The company was founded by Richard Jude Samulski, Xiao Xiao, and Sheila A. Mikhail in 2001 and is headquartered in Durham, NC.	Health Technology

See company connections